Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Measles, mumps, and rubella.

Literature DB >> 22510638

Measles, mumps, and rubella.

Sarah J White¹, Kristi L Boldt, Sara J Holditch, Gregory A Poland, Robert M Jacobson.

Abstract

Measles, mumps, and rubella are viral diseases that may adversely affect nonimmune pregnant women and their fetuses/neonates. Prevention of these diseases and their complications can be achieved through measles-mumps-rubella (MMR) vaccination before pregnancy. The vaccine is contraindicated during pregnancy, because it contains live, attenuated viruses that pose a theoretical risk to the fetus. However, accidental receipt of MMR vaccination is not known to cause maternal/fetal complications. MMR immunization is recommended to nonimmune obstetric patients upon completion or termination of pregnancy.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2012 PMID： 22510638 PMCID： PMC3334858 DOI： 10.1097/GRF.0b013e31824df256

Source DB: PubMed Journal: Clin Obstet Gynecol ISSN： 0009-9201 Impact factor: 2.190

11 in total

1. A maternal immunization program (MIP): developing a schedule and platform for routine immunization during pregnancy.

Authors: Stanley A Gall; Gregory A Poland
Journal: Vaccine Date: 2011-11-28 Impact factor: 3.641

2. Progress toward control of rubella and prevention of congenital rubella syndrome--worldwide, 2009.

Authors: S E Reef; P Strebel; A Dabbagh; M Gacic-Dobo; S Cochi
Journal: J Infect Dis Date: 2011-07 Impact factor: 5.226

Review 3. In utero diagnosis of congenital infections by direct fetal sampling.

Authors: P Valente; J L Sever
Journal: Isr J Med Sci Date: 1994 May-Jun

4. General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:
Journal: MMWR Recomm Rep Date: 2011-01-28

5. Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Authors:
Journal: MMWR Recomm Rep Date: 1996-09-06

6. Mumps outbreak - New York, New Jersey, Quebec, 2009.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 2009-11-20 Impact factor: 17.586

Review 7. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses.

Authors: Asher Ornoy; Alexander Tenenbaum
Journal: Reprod Toxicol Date: 2006-02-09 Impact factor: 3.143

8. Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine.

Authors: Charles W LeBaron; Bagher Forghani; Lukas Matter; Susan E Reef; Carol Beck; Daoling Bi; Cynthia Cossen; Bradley J Sullivan
Journal: J Infect Dis Date: 2009-09-15 Impact factor: 5.226

9. Update: measles--United States, January-July 2008.

Authors:
Journal: MMWR Morb Mortal Wkly Rep Date: 2008-08-22 Impact factor: 17.586

10. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: J C Watson; S C Hadler; C A Dykewicz; S Reef; L Phillips
Journal: MMWR Recomm Rep Date: 1998-05-22

16 in total

Review 1. Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.

Authors: Stephen J Russell; Dusica Babovic-Vuksanovic; Alice Bexon; Roberto Cattaneo; David Dingli; Angela Dispenzieri; David R Deyle; Mark J Federspiel; Adele Fielding; Eva Galanis; Martha Q Lacy; Bradley C Leibovich; Minetta C Liu; Miguel Muñoz-Alía; Tanner C Miest; Julian R Molina; Sabine Mueller; Scott H Okuno; Nandakumar Packiriswamy; Tobias Peikert; Corey Raffel; Frits Van Rhee; Guy Ungerechts; Paul R Young; Yumei Zhou; Kah-Whye Peng
Journal: Mayo Clin Proc Date: 2019-06-22 Impact factor: 7.616

2. Why, when and for what diseases pregnant and new mothers "should" be vaccinated.

Authors: Giovanni Gabutti; Giorgio Conforti; Alberto Tomasi; Parvanè Kuhdari; Paolo Castiglia; Rosa Prato; Silvia Memmini; Chiara Azzari; Giovanni Vitali Rosati; Paolo Bonanni
Journal: Hum Vaccin Immunother Date: 2016-12-08 Impact factor: 3.452

Review 3. T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors: Anne Monette; Andrew J Mouland
Journal: Int Rev Cell Mol Biol Date: 2018-10-24 Impact factor: 6.813

4. Measles in pregnancy.

Authors: Jassimran Bansal; Aisha Hameed
Journal: BMJ Case Rep Date: 2019-05-09

5. A Nationwide Study on the Seroprevalence of Measles, Mumps, and Rubella in Iranian Children and Adolescents.

Authors: Zary Nokhodian; Behrooz Ataei; Mohammad Mehdi Gouya; Shervin Ghaffari Hoseini; Majid Yaran; Marjan Mansourian; Mohammad Esmaeil Motlagh; Ramin Heshmat; Seyed Mohsen Zahraei; Roya Kelishadi
Journal: Iran J Public Health Date: 2022-02 Impact factor: 1.479

6. Respiratory syncytial virus seropositivity at birth is associated with adverse neonatal respiratory outcomes.

Authors: Sara Manti; Frank Esper; Marilyn Alejandro-Rodriguez; Salvatore Leonardi; Pasqua Betta; Caterina Cuppari; Angela Lanzafame; Sarah Worley; Carmelo Salpietro; Miriam K Perez; Fariba Rezaee; Giovanni Piedimonte
Journal: Pediatr Pulmonol Date: 2020-08-14

7. The period from prodromal fever onset to rash onset in laboratory-confirmed rubella cases: a cross-sectional study.

Authors: Tsuyoshi Ogata; Maki Murooka; Makoto Akashi; Akemi Ishitsuka; Akari Miyazaki; Shuuichi Osawa; Kanako Ishikawa; Keiko Tanaka-Taya; Ritei Uehara
Journal: BMC Infect Dis Date: 2021-05-15 Impact factor: 3.090

8. Epidemiological changes in rubella IgG antibody levels detected in antenatal women from a retrospective rubella seroprevalence study.

Authors: Ciara O'Connor; David Le Blanc; Richard J Drew
Journal: Ir J Med Sci Date: 2017-12-05 Impact factor: 2.089

Review 9. Genetically modified organisms and visceral leishmaniasis.

Authors: Rudra Chhajer; Nahid Ali
Journal: Front Immunol Date: 2014-05-14 Impact factor: 7.561

Review 10. The Influence of Vaccine on Febrile Seizure.

Authors: Xin Li; Yang Lin; Gang Yao; Yicun Wang
Journal: Curr Neuropharmacol Date: 2018 Impact factor: 7.363